Abstract
The mechanisms governing the development and progression of cancers are believed to be the consequence of hereditary deformities and epigenetic modifications. Accordingly, epigenetics has become an incredible and progressively explored field of research to discover better prevention and therapy for neoplasia, especially triple-negative breast cancer (TNBC). It represents 15-20% of all invasive breast cancers and will, in general, have bellicose histological highlights and poor clinical outcomes. In the early phases of triple-negative breast carcinogenesis, epigenetic deregulation modifies chromatin structure and influences the plasticity of cells. It up-keeps the oncogenic reprogramming of malignant progenitor cells with the acquisition of unrestrained selfrenewal capacities. Genomic impulsiveness in TNBC prompts mutations, copy number variations, as well as genetic rearrangements, while epigenetic remodeling includes an amendment by DNA methylation, histone modification, and noncoding RNAs of gene expression profiles. It is currently evident that epigenetic mechanisms assume a significant part in the pathogenesis, maintenance, and therapeutic resistance of TNBC. Although TNBC is a heterogeneous malaise that is perplexing to describe and treat, the ongoing explosion of genetic and epigenetic research will help to expand these endeavors. Latest developments in transcriptome analysis have reformed our understanding of human diseases, including TNBC at the molecular medicine level. It is appealing to envision transcriptomic biomarkers to comprehend tumor behavior more readily regarding its cellular microenvironment. Understanding these essential biomarkers and molecular changes will propel our capability to treat TNBC adequately. This review will depict the different aspects of epigenetics and the landscape of transcriptomics in triple-negative breast carcinogenesis and their impending application for diagnosis, prognosis, and treatment decision with the view of molecular medicine.
Keywords: Epigenetic reprogramming, triple negative breast cancer, genomic impulsiveness, transcriptome, biomarkers, treatment decision.
[http://dx.doi.org/10.1002/ijc.31937] [PMID: 30350310]
[http://dx.doi.org/10.7314/APJCP.2016.17.S3.43] [PMID: 27165206]
[http://dx.doi.org/10.1158/1055-9965.EPI-16-0858] [PMID: 28223433]
[http://dx.doi.org/10.3233/BD-2010-0319] [PMID: 21965309]
[http://dx.doi.org/10.1016/j.breast.2013.08.007] [PMID: 24063766]
[http://dx.doi.org/10.1093/annonc/mdt284] [PMID: 23970019]
[http://dx.doi.org/10.3747/co.v18i4.824] [PMID: 21874112]
[http://dx.doi.org/10.1615/CritRevImmunol.2020037044] [PMID: 33822523]
[http://dx.doi.org/10.2174/1566524020666200824103749] [PMID: 32838717]
[http://dx.doi.org/10.1056/NEJMra1001389] [PMID: 21067385]
[http://dx.doi.org/10.1002/path.4280] [PMID: 24114677]
[http://dx.doi.org/10.1634/theoncologist.2011-S1-61] [PMID: 21278442]
[http://dx.doi.org/10.3390/cancers9100134] [PMID: 28974015]
[http://dx.doi.org/10.1038/onc.2008.346] [PMID: 19029937]
[http://dx.doi.org/10.1038/s41598-019-44826-8] [PMID: 31165775]
[http://dx.doi.org/10.1155/2019/5810465] [PMID: 31275381]
[http://dx.doi.org/10.1158/1078-0432.CCR-16-2811] [PMID: 27965308]
[http://dx.doi.org/10.1038/s41467-020-14304-1] [PMID: 31980632]
[http://dx.doi.org/10.1126/science.aay0939]
[http://dx.doi.org/10.1038/s41388-020-1166-y] [PMID: 31988454]
[http://dx.doi.org/10.1016/j.gde.2017.03.015] [PMID: 28412585]
[http://dx.doi.org/10.3390/ijms18020308] [PMID: 28146134]
[http://dx.doi.org/10.1172/JCI45014] [PMID: 21633166]
[http://dx.doi.org/10.1371/journal.pone.0157368] [PMID: 27310713]
[http://dx.doi.org/10.1158/1078-0432.CCR-14-0432] [PMID: 25208879]
[http://dx.doi.org/10.1186/s13058-015-0550-y] [PMID: 25887482]
[http://dx.doi.org/10.1016/j.soc.2017.08.005] [PMID: 29132568]
[http://dx.doi.org/10.1186/s13058-020-01296-5] [PMID: 32517735]
[http://dx.doi.org/10.1186/s12885-019-5392-z] [PMID: 30849944]
[http://dx.doi.org/10.1016/j.ajpath.2017.04.022] [PMID: 28733194]
[http://dx.doi.org/10.1038/s41598-019-55710-w] [PMID: 31836816]
[http://dx.doi.org/10.1073/pnas.1018862108] [PMID: 21633010]
[http://dx.doi.org/10.1186/s13058-016-0724-2] [PMID: 27386846]
[http://dx.doi.org/10.3390/cancers11050723] [PMID: 31137727]
[http://dx.doi.org/10.2217/bmm-2018-0187] [PMID: 30041537]
[http://dx.doi.org/10.3390/cancers13040713] [PMID: 33572395]
[http://dx.doi.org/10.3390/jcm8050646] [PMID: 31083398]
[http://dx.doi.org/10.3109/03008207.2015.1060970] [PMID: 26291767]
[http://dx.doi.org/10.1038/s41392-020-0110-5] [PMID: 32296030]
[http://dx.doi.org/10.1016/j.gendis.2018.05.001] [PMID: 30258937]
[http://dx.doi.org/10.1016/j.semcancer.2018.11.004] [PMID: 30453041]
[http://dx.doi.org/10.5306/wjco.v5.i3.311] [PMID: 25114847]
[http://dx.doi.org/10.3892/ol.2016.5369] [PMID: 28105194]
[http://dx.doi.org/10.1088/1478-3975/aaffa1] [PMID: 30654341]
[http://dx.doi.org/10.3390/ijms21207624] [PMID: 33076339]
[http://dx.doi.org/10.1091/mbc.e08-05-0506] [PMID: 18799618]
[http://dx.doi.org/10.1016/j.yexcr.2017.04.006] [PMID: 28412244]
[http://dx.doi.org/10.3389/fphar.2019.00388] [PMID: 31057405]
[http://dx.doi.org/10.2174/1566524018666171205113959] [PMID: 29210650]
[http://dx.doi.org/10.1111/cas.12160] [PMID: 23551855]
[http://dx.doi.org/10.18632/oncotarget.15330] [PMID: 28212565]
[http://dx.doi.org/10.4161/rna.5.3.6558] [PMID: 19182522]
[http://dx.doi.org/10.3892/br.2016.747] [PMID: 27699004]
[http://dx.doi.org/10.1093/nar/gkx463] [PMID: 28531315]
[http://dx.doi.org/10.1016/j.molonc.2010.04.002]
[http://dx.doi.org/10.1038/s41392-019-0095-0] [PMID: 31871779]
[http://dx.doi.org/10.3390/genes11080922] [PMID: 32806509]
[http://dx.doi.org/10.3390/cancers12082123] [PMID: 32751889]
[http://dx.doi.org/10.3390/genes10020172] [PMID: 30813436]
[http://dx.doi.org/10.1002/1873-3468.13084] [PMID: 29749098]
[http://dx.doi.org/10.1158/0008-5472.CAN-10-4026] [PMID: 21363912]
[http://dx.doi.org/10.1186/s12864-018-4533-0] [PMID: 29458327]
[http://dx.doi.org/10.3390/ijms21238894] [PMID: 33255318]
[http://dx.doi.org/10.1002/ijc.29347] [PMID: 25410431]
[http://dx.doi.org/10.1371/journal.pone.0135865] [PMID: 26285011]
[http://dx.doi.org/10.1186/s13578-020-00415-1] [PMID: 32257110]
[http://dx.doi.org/10.1111/cas.13505] [PMID: 29345757]
[http://dx.doi.org/10.1038/s41586-020-1965-x] [PMID: 32025015]
[http://dx.doi.org/10.18632/oncotarget.17225] [PMID: 28477017]
[http://dx.doi.org/10.1186/s12943-018-0850-9] [PMID: 30007403]
[PMID: 24596345]
[http://dx.doi.org/10.1038/nature10983] [PMID: 22522925]
[http://dx.doi.org/10.1038/nature11412]
[http://dx.doi.org/10.1038/s41467-018-08200-y] [PMID: 30674876]
[http://dx.doi.org/10.7314/APJCP.2014.15.7.3041] [PMID: 24815444]
[http://dx.doi.org/10.1093/aje/kwp036] [PMID: 19318616]
[http://dx.doi.org/10.1371/journal.pone.0017490] [PMID: 21364760]
[http://dx.doi.org/10.1093/jnci/djq102] [PMID: 20388878]
[http://dx.doi.org/10.1186/s12575-018-0082-9] [PMID: 30214383]
[http://dx.doi.org/10.1155/2019/7252013] [PMID: 31929798]
[http://dx.doi.org/10.1371/journal.pone.0017830] [PMID: 21445275]
[http://dx.doi.org/10.1186/s13059-019-1870-5] [PMID: 31747960]
[http://dx.doi.org/10.2217/epi-2019-0312] [PMID: 32396394]
[http://dx.doi.org/10.1016/j.heliyon.2019.e02468] [PMID: 31687564]
[http://dx.doi.org/10.1007/s10549-009-0420-3] [PMID: 19459041]
[http://dx.doi.org/10.3390/molecules24162899] [PMID: 31404982]
[http://dx.doi.org/10.3390/ijms12074465] [PMID: 21845090]
[http://dx.doi.org/10.3390/cancers13040634] [PMID: 33562653]
[http://dx.doi.org/10.2217/fon.11.2] [PMID: 21345145]
[http://dx.doi.org/10.3389/fonc.2018.00092] [PMID: 29651407]
[http://dx.doi.org/10.3390/cancers11121911] [PMID: 31805711]
[http://dx.doi.org/10.3892/ol.2017.6204] [PMID: 28693231]
[http://dx.doi.org/10.2147/CMAR.S244606] [PMID: 32606959]
[http://dx.doi.org/10.1155/2017/4934608] [PMID: 29138528]
[http://dx.doi.org/10.3791/55773] [PMID: 28654059]
[http://dx.doi.org/10.1126/scitranslmed.3001875] [PMID: 21430268]
[http://dx.doi.org/10.1101/gad.325050.119] [PMID: 31123062]
[http://dx.doi.org/10.1186/s13244-020-00905-3] [PMID: 32975658]
[http://dx.doi.org/10.1148/radiol.2018172171] [PMID: 29782246]
[http://dx.doi.org/10.1142/S2339547818300020] [PMID: 30713991]
[http://dx.doi.org/10.1016/j.ejso.2017.02.003] [PMID: 28238520]
[http://dx.doi.org/10.1093/annonc/mdv215] [PMID: 25935792]
[http://dx.doi.org/10.1056/NEJMoa1602253] [PMID: 27557300]
[http://dx.doi.org/10.1056/NEJMoa1804710] [PMID: 29860917]
[http://dx.doi.org/10.1093/annonc/mdx308] [PMID: 28838210]
[http://dx.doi.org/10.1186/s13058-017-0911-9] [PMID: 29137653]
[http://dx.doi.org/10.1001/jamaoncol.2017.1261] [PMID: 28662222]
[http://dx.doi.org/10.1016/j.cellsig.2016.02.006] [PMID: 26876786]
[http://dx.doi.org/10.3390/cells8121656] [PMID: 31861179]
[http://dx.doi.org/10.4048/jbc.2018.21.e41] [PMID: 30275851]
[http://dx.doi.org/10.1016/j.drudis.2019.02.003] [PMID: 30776482]
[http://dx.doi.org/10.21873/cgp.20041] [PMID: 28870998]
[http://dx.doi.org/10.1016/j.semcancer.2018.01.007] [PMID: 29339244]
[http://dx.doi.org/10.1101/cshperspect.a026831] [PMID: 27599530]
[http://dx.doi.org/10.1200/JCO.2012.43.7251] [PMID: 23650416]
[http://dx.doi.org/10.1158/1078-0432.CCR-16-1729] [PMID: 27979916]
[http://dx.doi.org/10.1042/BSR20171357] [PMID: 29298879]
[http://dx.doi.org/10.18632/oncotarget.23169] [PMID: 29371976]
[http://dx.doi.org/10.2174/1568009620666210106122421] [PMID: 33413062]
[http://dx.doi.org/10.2174/1389201021666201211102710] [PMID: 33308128]
[http://dx.doi.org/10.2174/1574888X16666210203105800] [PMID: 33563175]
[http://dx.doi.org/10.1186/s12014-017-9179-4] [PMID: 29344009]
[http://dx.doi.org/10.3390/jcm7110420] [PMID: 30405052]
[http://dx.doi.org/10.3390/ijms19030900] [PMID: 29562656]
[http://dx.doi.org/10.1038/sj.bjc.6605042] [PMID: 19436308]
[http://dx.doi.org/10.7150/jca.22046] [PMID: 29158783]
[http://dx.doi.org/10.1016/j.molonc.2012.02.003] [PMID: 22406404]
[http://dx.doi.org/10.1186/s13058-020-1250-9] [PMID: 32005275]
[http://dx.doi.org/10.1200/JCO.18.02050] [PMID: 31050911]
[http://dx.doi.org/10.1038/s41416-018-0127-5] [PMID: 29867226]
[http://dx.doi.org/10.3390/cancers10120506] [PMID: 30544963]
[http://dx.doi.org/10.18632/oncotarget.19895] [PMID: 29152070]
[http://dx.doi.org/10.3389/fonc.2019.01388] [PMID: 31921645]
[http://dx.doi.org/10.1016/j.tcb.2019.07.008] [PMID: 31421928]
[http://dx.doi.org/10.1093/pcmedi/pbaa030] [PMID: 32983586]
[http://dx.doi.org/10.3390/cancers12061502] [PMID: 32526888]